Showing posts with label FDA approval of alectinib for lung cancer treatment. Show all posts
Showing posts with label FDA approval of alectinib for lung cancer treatment. Show all posts
Thursday, March 3, 2016

IASLC lauds FDA approval of alectinib for lung cancer treatment

›
The International Association for the Study of Lung Cancer (IASLC) is once again gratified to see the approval of a new second-generat...